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Insecticide resistance amongst disease vectors is a growing problem and novel compounds are needed.
Biogenic amines are important for neurotransmission and we have recently shown a potential role for these
inmosquito fertility. Here, we dissected the relative contribution of different aminergic signalling pathways
to biological processes essential for vectorial capacity such as fertility, locomotion and survival by injecting
agonists and antagonists and showed that octopaminergic/tyraminergic signalling is essential for
oviposition and hatching rate. We show that egg melanisation is regulated by adrenergic signalling, whose
disruption causes premature melanisation specifically through the action of tyramine. In addition to this,
co-injection of tyramine with DOPA, the precursor of melanin, had a strong cumulative negative effect on
mosquito locomotion and survival. Dopaminergic and serotonergic antagonists such as amitriptyline and
citalopram recapitulate this effect. Together these results reveal potential new target sites for the
development of future mosquito sterilants and insecticides.
A
s insecticide resistance is spreading in many insect vectors of disease new agents with novel modes of
action are needed. This is particularly the case for the principlemalaria vectorAnopheles gambiaewhere of
the 4 classes of insecticides currently used i.e. organochlorines1, pyrethroids2, organophosphates3 and
carbamates3, resistance has been documented for each. These insecticides act either through prolonged opening of
sodium channels or inhibition of acetylcholinesterase leading to neuronal overstimulation and death of the
vector.
G-protein-coupled receptors (GPCRs) comprise a large family of membrane-bound receptors found in verte-
brates and invertebrates which regulate different cell signalling pathways4,5. In insects they regulate major
biological processes such as reproduction, development, locomotion as well as feeding6 and thus provide novel
targets for insecticide discovery which have not yet been exploited.
One important class of messengers that primarily bind to GPCRs are biogenic amines. These can act as
neurotransmitters, neuromodulators and neurohormones7. We were interested in these compounds because
recently we showed in An. gambiae a drastic reduction in female fertility by knocking down a key enzyme
responsible for tyrosine and subsequent biogenic amine synthesis (dopamine, tyramine and octopamine)8. Life
traits such as oogenesis, flight behaviour and longevity are important determinants in the capacity of a mosquito
vector to transmit disease.With the goal of dissecting the aminergic pathways responsible for these behaviours we
focused on testing a series of biogenic amines and drugs which are known to bind dopaminergic, serotonergic and
adrenergic GPCRs in humans but whose function in mosquitoes is unknown.
Biogenic amines consist of 5members that can be found in vertebrates and invertebrates9. They are synthesised
from 3 amino acids (tyrosine, tryptophan or histidine) via multiple enzymatic steps. While humans and insects
both share dopamine, serotonin (5HT, 5-Hydroxytryptamine) and histamine, some amines are preferentially
synthesised in vertebrates or invertebrates (Figure 1). Indeed, the neurotransmitterstyramine and octopamine
that are widely distributed and highly abundant in insects10 are present only as traces in the mammalian nervious
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system compared to other biogenic amines such as adrenaline and
noradrenaline11. In adrenergic signalling in insects they are regarded
as the functional counterparts of noradrenaline and adrenaline in
humans12. Targeting the insect specific tyramine- gated chloride
channels13 or octopaminergic and tyraminergic adrenergic-like
receptors might represent a window for the development of novel
insecticides with minimal off-target effects on non-arthropods.
The octopamine receptor agonist amitraz has been successfully
used as pesticide against ticks14–16 as well as parasitic mites17, but
its application to mosquitoes has not been explored. Moreover, the
potential of tyramine, the metabolic precursor of octopamine, has
been largely neglected. However, increases in tyramine levels either
by injection of tyramine or knockdown of tyramine beta hydroxylase
(TBH), the enzyme that converts tyramine to octopamine, have also
been shown to inhibit insect oviposition18,19. Further, administration
of tyramine causes opposing effects to octopamine in insect loco-
motion20,21. Similar to tyramine and octopamine, dopamine and
serotonin (5-HT) are important for egg laying and locomotor beha-
viour22–25. However, in contrast to the oviposition effect seen in TBH
mutants, insects withmutations in dopa decarboxylase (DDC) essen-
tial in the synthesis of serotonin and dopamine, die as embryos26
highlighting the differing importance of these amines for separate
aspects of insect body function. Recently amitriptyline, a serotonin
antagonist has been identified as selective dopamine 2 receptor
(Dop2) antagonist in the dengue and yellow fever mosquito Aedes
aegypti causing high larvalmortality27. Since fertility, locomotion and
survival represent important factors that determine the ability of the
mosquito to transmit disease-causing parasites, negatively affecting
these life history traits through interfering with biogenic amine syn-
thesis or function, could represent a new tool for control of vector-
borne diseases. We set out to investigate this possibility through a
series of experiments testing a range of different aminergic receptor
agonists and antagonists for their effects on the mosquito.
Results
Evolutionary relationships between selected human aminergic
receptors and insect biogenic amine receptors. On the assump-
tion that the level of evolutionary relatedness of different GPCRs
should positively correlate with conservation of function and
ligand partner, we performed a phylogenetic analysis of the
different human, fruit fly and malaria mosquito GPCRs (Figure 2).
As expected the aminergic GPCRs of two dipteran GPCRs were
closer related to each other than to the human GPCRs and formed
clusters that have been classified previously28–30. Our bootstrapping
analysis further supported clades formed by the insect dopaminergic
receptors (Dop1, Dop3), serotonergic receptors (5HT1,5,7) and a2
adrenergic-like octopamine receptors (OA3) with the respective
human D1, D2, 5-HT and a2 adrenergic receptors. This was in
concordance with pharmacological studies investigating GPCRs in
insects which highlight potential functional similarities between
human and insect GPCRs (Table 1). This close relationship
between human and insect receptors could potentially limit the
insecticidal application of molecules that target these GPCRs.
Interestingly, none of the tyraminergic receptors (Tyr1-3) clustered
together with the respective human adrenergic receptors, therefore
molecules targeting those receptors might be more suitable to
generate insect specific insecticides. Nonetheless, there are exam-
ples of clear differences in pharmacological responses of drugs
against phylogenetically related receptors and even between
different insect genera27. For example tick and Aedes mosquito D1
like receptors can be inhibited by Sch2339027 while no effect is
observed on the fruitfly31 or honey bee Dop1 receptor32. This
highlights on one hand the opportunity to potentially generate
mosquito specific agents but also the need to test empirically each
compound on its merit for the species of interest.
Perturbation of the adrenergic system and dopamine availability
inhibits female fertility. Our recent results showed that pheny-
lalanine hydroxylase activity, which catalyzes the first step of
phenylalanine metabolism by converting phenylalanine into
tyrosine, is needed for oviposition and egg formation in An.
gambiae mosquitoes8. Tyrosine is an essential precursor in the
formation of insect neurotransmitters tyramine, octopamine and
dopamine. In order to dissect the potential involvement of these
biogenic amines in female mosquito fertility, we injected females
with different agonists and antagonists of the adrenergic system
and compounds involved in dopamine synthesis. The strongest
effect on egg laying ability was observed by injection of tyramine,
which resulted in complete inhibition of oviposition (Figure 3A).
Oviposition rate was also reduced by 16% by the tyramine-derived
neurotransmitter octopamine and by 28% by the a2-adrenergic
agonist clonidine, compared to the PBS-injected control. We
observed that relatively few compounds (octopamine, dobutamine
and dopamine) had an effect on the number of eggs laid, possibly due
to the fact that injection of compounds coincided with the latter
stages of oogenesis, when oocytes would be expected to be
fully formed (Figure 3B). However, many compounds (the a2-
adrenergic agonist clonidine, a1-antagonist prazosin, the b2-
agonist clenbuterol and the DDC inhibitor carbidopa) that had no
effect on clutch size had a negative impact on embryo viability as
measured by larval hatching rate (Figure 3C). Interestingly this effect
seemed to be due to either the specific activation or inactivation of
each of the different adrenergic receptors and the injection of
compounds with putative opposing function on a2-receptors
(yohimbine, antagonist), a1 receptors (phenylephrine, agonist) and
b-receptors (acebutolol, sotalol, both antagonists) had no effect.
Reduction in embryo viability by carbidopa on the other hand
could have been due to the fact that it targets dopa decarboxylase
(DDC) which has a likely role in the formation of the embryo serosa,
a protective membrane that can enclose the entire embryo33.
Tyramine injection induced a preoviposition egg melanisation
phenotype which can be modulated via a-adrenergic inhibition.
Since all tyramine-injected females failed to lay eggs, we dissected
their ovaries to examine egg development. Most eggs retained by
females appeared to be melanised (Figure 4A). This tyramine-
Figure 1 | Biosynthesis pathway of biogenic amines in invertebrates and
vertebrates. DBH- dopamine b- hydroxylase, DDC- Dopa decarboxylase,
PNMT- phenyl ethanolamine-N-methyltransferase, PO- phenoloxidase,
TDC- tyrosine decarboxylase, TBH- tyramine beta hydroxylase, TPH-
tryptophan hydroxylase. The green and blue squares mark the metabolic
reactions specific for either invertebrates or vertebrates respectively. The
dotted arrow represents a salvage pathway which might exist12. Its
physiological relevance is unknown.
www.nature.com/scientificreports
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mediated premature melanisation phenotype was very unusual, as
An. gambiae eggs ordinarily melanise only after oviposition. It is
possible that the reduced oviposition phenotype in tyramine-
injected females was directly due to premature melanisation of
eggs and concomitant chorion hardening that prevented their
physical release from the ovary rather than a behavioural effect on
oviposition stimulus. Interestingly, when we injected DOPA or
dopamine, known precursors of melanin34 or any other adrenergic
compounds, we did not observe this premature melanisation
phenotype, suggesting a tyraminergic regulatory mechanism for
this process (Figure 4B). To investigate this further we tried to
rescue this melanisation effect in two ways: 1) by inhibition of
melanin synthesis through injection of carbidopa that inhibits the
dopa decarboxylase (DDC) essential for dopamine melanin and
sclerotin synthesis; 2) antagonising injected tyramine activity with
its antagonists prazosin or yohimbine. Fewer eggs were fully
melanised in the presence of prazosin or yohimbine, suggesting a
tyraminergic pathway is responsible for this effect (Figure 4C). We
observed only a very low proportion of females was able to lay eggs
following injection with any of the above compound combinations
(Figure 4D) but we cannot exclude the possibility that general
toxicity of these combinations contributed to low egg number and
oviposition rate (Figure 4E). Carbidopa did not reduce tyramine-
induced pre-oviposited egg melanisation but it did inhibit
Figure 2 | Phylogenetic analysis of selected human, fly and mosquito biogenic amine receptors. Protein sequences of each receptor (‘‘R’’) were first
aligned in Muscle47 and then a Maximum-Likelihood tree was constructed in MEGA 6 using 1000-fold bootstrap re-sampling. All insect receptors are
shown in green, while the human receptors are highlighted in blue. The numbers at the nodes of the branches represent the level of bootstrap support for
each branch. TheD.melanogaster FMRF amide receptor (DmFR, AAF47700.1) was used as outgroup. The accession numbers for each receptor are listed
in Supplementary Table S1.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5526 | DOI: 10.1038/srep05526 3
Ta
bl
e
1
|A
dr
en
er
gi
c,
do
pa
m
in
er
gi
c
an
d
se
ro
to
ne
rg
ic
ac
tio
n
of
co
m
po
un
ds
ap
pl
ie
d
in
hu
m
an
s
an
d
in
se
ct
s
co
m
po
un
d
fu
nc
tio
n
in
hu
m
an
s
fu
nc
tio
n
in
in
se
ct
s
Re
fe
re
nc
e
Ty
ro
si
ne
Pr
ec
ur
so
ro
fD
O
PA
,d
op
am
in
e,
ad
re
na
lin
e
an
d
no
ra
dr
en
al
in
e
Pr
ec
ur
so
ro
fD
O
PA
,d
op
am
in
e,
ty
ra
m
in
e
an
d
oc
to
pa
m
in
e
[4
8]
L-D
O
PA
D
(1
-4
)d
op
am
in
e
re
ce
pt
or
ag
on
is
t,
do
pa
m
in
e
pr
ec
ur
so
r
D
op
am
in
e
an
d
D
O
PA
m
el
an
in
pr
ec
ur
so
r,
[4
8–
50
]
D
op
am
in
e
D
(1
-4
)d
op
am
in
e
re
ce
pt
or
ag
on
is
t,
do
pa
m
in
e
tra
ns
po
rt
in
du
ce
r,
do
pa
m
in
e
be
ta
hy
dr
ox
yl
as
e
lig
an
d,
do
pa
m
in
e
m
el
an
in
pr
ec
ur
so
r,
D
op
1-
3
re
ce
pt
or
ag
on
is
t,
O
ct
a
2R
(O
A
3)
ag
on
is
t,
Ty
R1
an
d
Ty
R3
ag
on
is
t
[2
7,
29
,3
0,
38
,5
1,
52
]
C
ar
bi
do
pa
A
ro
m
at
ic
am
in
o
ac
id
de
ca
rb
ox
yl
as
e
(A
A
D
C
)i
nh
ib
ito
r
D
D
C
in
hi
bi
to
r
[5
3,
54
]
Ty
ra
m
in
e
Tr
ac
e
am
in
e
as
so
ci
at
ed
re
ce
pt
or
(T
A
A
R)
ag
on
is
t,
b
-a
dr
en
er
gi
c
re
ce
pt
or
1
an
d
2
(A
D
BR
1,
2)
an
ta
go
ni
st
O
ct
a
2R
(O
A
3)
ag
on
is
t,
Ty
R1
-3
ag
on
is
t,
D
op
3
(D
2
lik
e)
ag
on
is
t
[2
9,
30
,3
8,
45
,5
5–
57
]
O
ct
op
am
in
e
TA
A
R
ag
on
is
t,
A
D
RB
2-
an
ta
go
ni
st,
A
D
RB
1,
3-
ag
on
is
t
O
ct
a
2R
(O
A
3)
ag
on
is
t,
Ty
R
1
ag
on
is
t,
O
ct
b
R
(O
A
2)
ag
on
is
t,
Ty
R3
ag
on
is
t
[2
9,
30
,3
8,
57
–5
9]
C
lo
ni
di
ne
a
2
ad
re
ne
rg
ic
ag
on
is
t
Ty
R
.
O
ct
R
ag
on
is
t,
O
ct
a
2R
(O
A
3)
ag
on
is
t,
O
ct
R
1
(O
A
1)
ag
on
is
t
[3
0,
60
,6
1]
Yo
hi
m
bi
ne
a
2,
5-
H
T(
1B
),
5-
H
T(
1D
),
an
d
D
(2
)r
ec
ep
to
ra
nt
ag
on
is
t,
5H
T
(1
A
)
ag
on
is
t
Ty
R
1
an
ta
go
ni
st,
5-
H
T1
,2
,7
an
ta
go
ni
st,
O
ct
R1
(O
A
1)
an
ta
go
ni
st,
Ty
R.
O
ct
R
an
ta
go
ni
st
[2
8,
30
,4
5,
61
–6
4]
Pr
az
os
in
a
1
an
ta
go
ni
st
Ty
R1
(O
ct
/T
yr
)a
nt
ag
on
is
t,
5-
H
T1
,7
an
ta
go
ni
st,
O
ct
R
an
ta
go
ni
st
[5
8,
61
,6
5,
66
]
Ph
en
yl
ep
hr
in
e
a
1
ag
on
is
t
Ty
R
ag
on
is
t,
O
ct
R
ag
on
is
t
[6
7,
68
]
C
le
nb
ut
er
ol
b
2
ag
on
is
t
N
D
[6
9]
D
ob
ut
am
in
e
b
1
an
d
a
1
ag
on
is
t
N
D
[7
0]
A
ce
bu
to
lo
l
b
1
an
ta
go
ni
st
N
D
[7
1]
So
ta
lo
l
N
on
-se
le
ct
iv
e
b
-b
lo
ck
er
N
D
[7
2]
A
m
itr
ip
ty
lin
e
N
or
ad
re
na
lin
e
an
d
se
ro
to
ni
n
tra
ns
po
rt
(S
ER
T)
in
hi
bi
to
r,
5H
T-
2A
re
ce
pt
or
an
ta
go
ni
st,
Tr
kA
an
d
Tr
kB
re
ce
pt
or
ag
on
is
t
D
op
2
an
ta
go
ni
st
[2
7,
73
–7
7]
Sc
h-
39
16
6
(E
co
pi
pa
m
)
D
1
re
ce
pt
or
an
ta
go
ni
st
N
D
[7
8]
SK
F-
38
39
3
D
1
re
ce
pt
or
ag
on
is
t
D
op
am
in
e
1
re
ce
pt
or
(D
op
1)
ag
on
is
t
[2
7,
79
]
D
om
pe
rid
on
e
D
2,
D
3
re
ce
pt
or
an
ta
go
ni
st
D
op
3
(D
2
lik
e)
an
ta
go
ni
st
[8
0,
81
]
Br
om
oc
rip
tin
e
D
2,
D
3,
5-
H
T
re
ce
pt
or
ag
on
is
t,
a
2-
ad
re
ne
rg
ic
,D
1
re
ce
pt
or
an
ta
go
ni
st,
in
ac
tiv
at
es
do
pa
m
in
e
D
4
an
d
5-
H
T7
re
ce
pt
or
s
D
op
3
(D
2
lik
e)
ag
on
is
t
[5
5,
82
,8
3]
Se
ro
to
ni
n
(5
H
T)
5-
H
T
ag
on
is
t
5H
T1
,2
,7
ag
on
is
t,
D
op
3
(D
2
lik
e)
ag
on
is
t
[5
5,
61
,6
3,
66
]
5-
M
et
hy
l-N
,N
-
di
m
et
hy
ltr
yp
ta
m
in
e
(5
-M
eO
-D
M
T)
5-
H
T
ag
on
is
t
5-
H
T2
ag
on
is
t
[6
3,
84
]
Ke
ta
ns
er
in
5-
H
T
an
ta
go
ni
st
5-
H
T2
an
ta
go
ni
st
[6
3,
85
]
C
ita
lo
pr
am
SE
RT
in
hi
bi
to
r
N
D
[8
6]
N
D
-n
ot
de
te
rm
in
ed
.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5526 | DOI: 10.1038/srep05526 4
melanisation post-oviposition and this was rescued by the addition
of DOPA, suggesting that at that stage melanisation depends highly
on dopamine availability (Figure 4F).
Locomotor activity is severely disturbed by activation of the
adrenergic system and inhibition of the dopaminergic and
serotonergic system. Normally, following anaesthesia with a brief
pulse of CO2, mosquitoes will require several minutes to regain
posture and be able to fly again. However, in our oviposition
assays we observed that upon injection of tyramine, clonidine,
clenbuterol and tyramine 1 DOPA females required a longer
recovery period post-anaesthesia of more than 2 h. In addition
tyramine-injected females showed leg tremors and flight inability
during that time and most of the tyramine 1DOPA injected
females died. This suggested that we were able to interfere in
neuromuscular transmission which is required for mosquito
locomotor behaviour. This is in concordance with previous studies
that have shown that biogenic amines can modulate this function in
other insect species35,36. To ascertain the relative contribution of the
adrenergic and dopaminergic pathways to locomotor activity we
injected female mosquitoes with a panel of agonists/antagonists
that are known to interfere in these pathways in the human
nervous system and measured the post-immobilisation recovery
(PIR) time as a proxy for regain of locomotive function. We then
classified the outcome in 3 groups (Figure 5A): PIR not statistically
different from PBS-injected controls (green line); significant longer
PIR but .50% recovery within 3 h (orange line); significant longer
PIR but ,50% recovery within 3 h (red line). Our results showed
that in general drug-mediated dopamine receptor antagonists (Sch-
39166, amitriptyline), a-adrenergic (tyramine, clonidine, prazosin)
and b-adrenergic (sotalol, acebutolol, dobutamine and clenbuterol)
agonists and antagonists prolonged PIR significantly. The antagonist
yohimbine was able to reverse the negative effect of tyramine on the
locomotory behaviour. Although amitriptyline has been recently
identified as dopamine receptor (Dop2) antagonist in Ae. aegypti,
this compound has been characterised in humansmainly as inhibitor
of the re-uptake of serotonin and noradrenaline37. In order to test
whether the prolonged PIR seen in amitriptyline-injected females
could be also caused by interference in the serotonergic system we
tested other serotonergic agonists and antagonists. Indeed,
compounds that are known to inhibit serotonin receptors
(ketanserin) or serotonin re-uptake (citalopram) in human
nervous system caused a significant increase in PIR. Citalopram
and combinatory injections of amitriptyline with dopamine
showed the strongest effect of all tested aminergic molecules even,
in the case of citalopram, at concentrations as low as 0.25 mM (data
not shown). The fact that dopamine co-injection did not rescue the
effect of amitriptyline suggests that amitriptyline affects non-
dopaminergic signalling in An. gambiae mosquitoes. Moreover,
dopamine actually prolonged the PIR in coinjection with
amitriptyline as well as with the alpha agonists tyramine and
clonidine. Potentially these effects could be caused either by an
increased imbalance between the different aminergic systems or by
dopamine binding also to the respective adrenergic or serotonergic
receptors thereby aggravating the effect caused by tyramine,
clonidine or amitriptyline alone. The latter hypothesis is supported
by studies which found that dopamine is an Oct a2R (OA3), TyR1
and TyR3 agonist in the insect nervous system30,38. However, it also
seems plausible that a balance of these systems is essential as often
different biogenic amines have opposing effects on behaviours such
as egg laying and locomotion in insects25,39.
Most of the females which were not able to resume flying within
3 h died within 24 h (Figure 5B).
Together, these results showed that disruption of the b-adrenergic
signalling, activation of the a2-adrenergic system, inactivation of the
a1-adrenergic system, inhibition of the D1-aminergic receptor or
Figure 3 | Female fertility after injection of adrenergic and dopamine-
related compounds. (a) Mean 6 standard error of the mean (SEM)
proportion of females that oviposited (N510 per experiment). The
Fisher’s exact Test was used to determine the Likelihood of oviposition of
the PBS control vs. compound from a minimum of 3 experiments, red
error bars indicate p,0.05. (b) Mean 6 SEM number of eggs per
ovipositing female (Mann Whitney test, in red p,0.05), N/A not
applicable. (c) Mean 6 SEM hatching rate of eggs laid per female
(Student’s t-test, in red p,0.05).
www.nature.com/scientificreports
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Figure 4 | Premature egg melanisation phenotype mediated by tyramine. (a) Ovary dissection of PBS (control) and tyramine-injected females 3 days
post-bloodmeal. (b) Representative examples of eggs dissected from female ovaries ,24 h after aminergic compound injection. (c) Mean 6 SEM
melanisation ratio of egg batches dissected from ovaries of 31–35 injected females from 3 repeats. (d) Mean 6 SEM number of eggs laid by females
following injection of tyramine alone or in combination with other compounds (N510 per experiment, minimum of 3 experiments, Student’s t-test, in
red p,0.05). (e) Proportion of females that survived 24 h post-injection with compounds (N510, minimum of 3 repeats, Student’s t-test, in red
p, 0.05). (f) Mean 6 SEM melanisation ratio of egg batches laid by injected females (N510 per experiment, 3 experiments, Student’s t-test, in red
p, 0.05).
www.nature.com/scientificreports
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Figure 5 | Effect of aminergic compounds on flying ability and survival. (a) Flying ability of females in response to injection of aminergic compounds at
various concentrations after CO2 knockdown (N515). Effects were grouped in 3 classes: in green - no effect; in orange- significant effect, but 50% of
females recovered within 3 h; in red- significant effect, recovery lower than 50% within 3 h. The experiment was performed in a minimum of 3
independent repeats. Curves were analysed by non-linear regression (one phase association, constraint: plateau level lower than 0.7, extra sum of squares
F- test, p,0.05 is significant). ND-not determined (b) Survival rate of 15 females injected with compounds that caused significant effects on flight
recovery (N515 per experiment, 3 repeats, Student’s t-test, p,0.05 is significant).
www.nature.com/scientificreports
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serotonin transport/receptors can each cause defects in the female
locomotor behaviour which can result further in adult death. A
detailed analysis of the locomotor behaviour following injection
showed that interferences in the different aminergic systems caused
distinct behavioural phenotypes (Supplementary Figure S1).
Amitriptyline, citalopram and tyramine are toxic for mosquito
larvae. Finally, we tested a range of the same compounds that
showed adult toxicity for their effect in larval stages. The most
potent of these compounds was amitriptyline, which at a
concentration of 0.4 mM killed more than 90% of larvae within
24 h (Figure 6A). This is comparable to its activity in the yellow
fever mosquito Ae. aegypti27. Tyramine and citalopram were able
to kill larvae but required significantly higher concentrations
(40 mM) (Figure 6B).
Discussion
Biogenic amines are responsible for the regulation of major physio-
logical processes. They have been extensively studied in humans and
recent progress has been made to evaluate their function in insects12.
We recently showed that the knockdown of a key enzyme involved in
phenylalanine/tyrosine metabolism caused reduced fertility in the
malaria mosquito8. Because this pathway also regulates the synthesis
of 3 of the 5 insect biogenic amines we investigated how amines and
drugs known to bind aminergic receptors can affect behaviours that
determine reproductive capacity and survival in An. gambiae mos-
quitoes. The injection of tyramine, the insect equivalent of the
human noradrenaline/adrenaline caused complete egg retention by
the gravid female and premature egg melanisation. It is possible that
rigidity of the chorion following melanisation could have attributed
to the observed complete sterility; however, because other adrenergic
compounds (clonidine and octopamine) also reduced oviposition
but did not cause premature egg melanisation other factors that
regulate oviposition must be important. Potentially, these could be
linked to an inability to contract the oviduct muscle, which has been
found to be the primary cause for sterility in Drosophila mutants
unable to convert tyramine into octopamine due to defective tyra-
mine beta hydroxylase19,40–42.When applied to isolated locust oviduct
muscles, octopamine has been shown to cause reduced muscle con-
tractions that are mediated via octopamine receptors43,44. Octopa-
mine and clonidine might bind preferentially different adrenergic
receptors compared to tyramine in mosquitoes. In fact clonidine is
an a2- agonist which has been shown in some studies to bind with
higher affinity to the a2- adrenergic like octopamine receptor rather
than the adrenergic TyR1 receptor in insects30,45. Assuming these
compounds bind to different adrenergic receptors, this would
explain the lack of premature egg melanisation observed upon octo-
pamine and clonidine injection. The regulation of melanin produc-
tion via adrenergic compounds has been also recently observed in
ticks whereby injection of the a2-adrenergic agonist guanabenz acet-
ate caused whole body melanisation18. In our case, the melanisation
induced by tyramine seemed to be limited to the eggs. Given these
results, we therefore propose that oviposition is regulated via the
octopaminergic and tyraminergic system, but that egg melanisation
is mediated via the tyraminergic/alpha 2 adrenergic system in An.
gambiae mosquitoes.
In line with tyraminergic regulation of egg chorion melanisation
the injection of the adrenergic antagonists prazosin and yohimbine
reduced the level of premelanisation of eggs. We could not confirm
this for the dopamine synthesis inhibitor carbidopa, although we
previously showed that its injection can cause reduced melanisation
of oviposited eggs. Interestingly, injection of DOPA or dopamine in
itself did not result in premature egg melanisation, indicating again
that these melanin precursors are insufficient to cause melanisation
alone and that regulatory mechanisms for this process must exist.
Some of the compounds, such as clonidine, prazosin, and clenbu-
terol did not lead to a reduction in egg numbers in contrast to the
mentioned previous study in ticks18, however these compounds
reduced embryo viability significantly. Changes in the availability
of dopamine via DOPA, dopamine or carbidopa injection also affec-
ted embryo viability. Reasons for the lack of effect in egg numbers
compared to the previous study in ticks could be due to the time of
injection relative to egg development. While ticks continuously pro-
duce egg batches, so that any egg laying defect caused by injectionwill
be seen immediately, An. gambiae mosquitoes lay eggs in discrete
batches only every 2–3 days after blood meal therefore the timing of
injection may be crucial. In order to observe a maximal effect on egg
laying ability and considering the short half-life of some of the com-
pounds, we injected mosquitoes,2–3 hours before we allowed ovi-
position. At that stage mosquito eggs are well developed, therefore
any effect on egg synthesis by these compounds might have been
diminished. Thus, potentially more of these compounds could affect
the number of eggs laid if the females were injected at an earlier stage.
We also found that several adrenergic, dopaminergic and serotono-
nergic compounds affect the adult locomotor behaviour, which sim-
ilar to female reproduction is obviously a determining factor for
mosquito vectorial capacity. Interference in the adrenergic system
by a2-agonists, a1-antagonists, b-agonists and antagonists led to
reduced flight recovery. The b2-agonist clenbuterol was particularly
effective, but over 40% of females recovered within 24 h. In contrast
to this, at the same concentration inhibition of the dopaminergic and
serotonin transport/receptor system by amitriptyline and citalopram
led to a severe effect on flight recovery but also increased adult
mortality to 80–100 percent within 24 h. Interestingly, in combina-
tion with dopamine, which in itself did not have an effect on loco-
motor activity or survival, the inhibitory effect of tyramine, clonidine
and amitriptyline was accentuated. This could have been caused by
dopamine binding to the respective adrenergic or serotonergic recep-
tors or imbalances between the different aminergic systems. Dopa-
mine has been found to bind various octopamine and tyramine
receptors in insects and activation of different aminergic systems can
cause opposing effects, highlighting the importance of a critical balance
between these systems to maintain body function25,39. Combinatory
insecticides which activate one system but inhibit another could be
therefore more effective in killing mosquitoes. Our compound con-
centrations used were comparable to other studies22 validating dopa-
minergic compounds. It remains to be seen how these correlate to
concentrations that would be required in aerosol for our compounds
to affect processes, such as oviposition, locomotion or respiration.
We finally tested whether adrenergic, dopaminergic and seroto-
nergic molecules would be effective larvicides. We found that
Figure 6 | Larval survival in the presence of dissolved tyramine,
citalopram and amitriptyline. (a) In 5 repeats the survival of 10 larvae per
treatment (final concentration: 40 mM, 1 mM, 400 uM, 100 uM) was
monitored and compared to the PBS control over a period of 24 h.
(Student’s t-test, p,0.05 is significant). (b) Larval survival rate (N510)
within 6 h after rearing in 40 mM compound solution.
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although tyramine, citalopram and amitriptyline were able to signifi-
cantly reduce larval survival rapidly, the latter was themost toxic and
killed larvae at a dosage that was equivalent to other pesticides14. This
was in concordance with a previous finding which showed that ami-
triptyline can be effective at killing Ae aegypti larvae27.
Overall we conclude that adrenergic compounds, in particular
those activating the adrenergic system, are effective mosquito ster-
ilants. Using compounds that mimic the action of tyramine could be
advantageous because tyramine only occurs at low concentrations in
vertebrates but at relatively high concentrations in insects, reflecting
its greater usage as a neurotransmitter in insects. However, adrener-
gic compounds in general were less effective at limiting mosquito
locomotion and larval/adult survival than dopamine receptor
antagonists or serotonin transport-inhibiting reagents. We further
showed that the behavioural effects can be various and distinct for
these compounds.
Injection of putative agonists and antagonists of neurotransmitter
signalling is an approach that has been used in the initial screening of
compounds with potential insecticidal properties in a wide range of
insects and arachnids18,22,46. In order to develop the aminergic com-
pounds tested here further research investigating their pharmaco-
logical properties and their specific binding tomosquito receptors by
using heterologous expression systems is needed. Nonetheless we
provide a useful experimental framework to study the effect of these
compounds on important life history traits as a first step in the future
development of aminergic insecticides.
Methods
Ethics Statement. All animal work was conducted according to UK Home Office
Regulations and approved under Home Office License PPL 70/6453.
Anopheles Rearing. The Anopheles gambiae G3 strain was maintained on 10%
glucose solution at 28uC and 80% humidity with 12/12 h day-night light cycle.
Oviposition assay. In order to investigate the effect of adrenergic and dopamine
related compounds on ovipostion and egg maturation, females were blood-fed and
then injected at a late stage of oogenesis (,53 h post blood meal) into the thorax
either with PBS solution or compound concentration of160 mM in PBS. Compounds
were purchased from Sigma and resuspended in PBS prior to injection. The females
were then allowed to recover from injection for 2 h before being placed into
oviposition cups for egg laying in a minimum of 3 independent experiments. The
likelihood of oviposition was analysed by Fisher’s exact-test, the number of eggs and
hatching rate was compared to the respective PBS control samples byMannWhitney
test and t-test of arc-sine transformed data withWelsh’s correction respectively using
the GraphPad Prism software. The proportion of females that survived was
determined 24 h post-injection and analysed by t-test in 3 independent experiments
(N510 per experiment).
Ovary dissection. In order to investigate premature egg melanisation, females were
prevented from egg laying and dissected 24 h after injection. Ovaries were removed
by pulling out the last 2 abdominal segments and inspected for melanisation under
the dissection microscope. The arc-sine transformed proportion of dark melanised
eggs was analysed between tyramine and coinjected females with tyramine with
DOPA, DOPA 1 carbidopa, carbidopa, yohimbine and prazosin by using a Student’s
t-test.
Flight recovery assay. Fifteen 1–2 day old adult females were anaesthetized on a CO2
pad and injected in their thorax with 69 nl of the compound at various concentrations
(80 mM, 40 mM or 10 mM). The total time of anaesthesia was ,2–3 min. Females
were then allowed to recover in paper cup. Every 15 min. the paper cap was tapped at
the bottom 3 times to induce flying behaviour. The proportion of females able to fly
per cup/condition was recorded for 3 h. After 24 h we recorded the number of
females alive. The flight recovery responses were analysed in GraphPad Prism by
non-linear regression comparing each compound vs. the respective PBS repeats
(exponential one-phase association equation with plateau constraint level of less than
0.7 and comparison of curves by using extra sum of squares F- test).
Behavioural analysis. After compound injection and anaesthesia 3 3 5 females were
placed on their back (which we refer to as basal stage) into a round glass bowl radius
8 cm, height 3.5 cm which served as observation arena. The bottom of this bowl was
covered with white filter paper (Whatman) to prevent females from sticking to the
glass while on top we placed a transparent petri dish lid. Females were allowed to
acclimate for 15 min. before the bottom of the bowl was tapped 3 times and their
behavioural response was video recorded for 1 min. This procedure was repeated
after 30 min, 45 min, 1 h and 3 h. We then analyzed the video by tracking each
individual female for the entire minute and scoring the following behaviours as
mutually exclusive: 1) the stationary behaviours: on back, upright (nomovement) and
2) other behaviours: leg and wing movement without taxis, walking, flying, jumping,
grooming, falling over and seizures. Jumping refers to a sudden leap (max. 1 sec) by
the mosquito without movement of wings. When mosquitoes rubbed their legs we
considered this behaviour as grooming. Falling over described a situation in which the
female loses balance and overturns. Females with seizures showed convulsions with
rapid uncontrolled movements of the body. A behavioural profile corresponding to
the injected compound was determined by measuring how much time injected
females spent in each behaviour, adding up to a total of 100%. We analysed the mean
behavioural profile of 15 females per compound by Student’s t-test. All observations
were performed at the mosquito day cycle and the multiple treatment groups were
performed in a randomized order.
Larval survival assay. 10 L2–L3 larvae were placed per well of a 24well Nunc plate
(VWR). Amitriptyline, tyramine and citalopramwere dissolved in PBS and added at a
final concentration of 40 mM, 1 mM, 400 mM or 100 mM to the well (total volume:
2 ml). 5 repeats were performed for the all but the 40 mM concentration. Larval
movement was recorded daily by gentle tapping on the Nunc plate. Non-moving
larvae were recorded as dead when touched with a pipette.
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